Paper39009593
Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinoma.
Culliford R and 18 others. Nat Commun, 2024. Cited by 17 papers, by iCite.
Cite this record
ConductScience Library. Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinoma. Papers, record 39009593. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39009593
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Renal Cell | Major topic |
| Kidney Neoplasms | Major topic |
| Whole Genome Sequencing | Major topic |
| Mutation | Major topic |
| Von Hippel-Lindau Tumor Suppressor Protein | Major topic |
| Humans | |
| Prognosis | |
| Male | |
| Female | |
| DNA Copy Number Variations | |
| Middle Aged | |
| Epigenesis, Genetic | |
| Aged | |
| Gene Expression Regulation, Neoplastic | |
| Immunotherapy |
Source PubMed
Grants9
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| FC10988 | RCUK | Medical Research Council (MRC) | PubMed | PubMed | ||
| 686061 | Melanoma Research Alliance (MRA) | PubMed | PubMed | ||
| 29911 | Cancer Research UK | United Kingdom | PubMed | PubMed | |
| U01 CA247439 | NCI NIH HHS | United States | U01CA247439 | PubMed and NIH | NIH RePORTER |
| A2204 | Rosetrees Trust | PubMed | PubMed | ||
| 214388, FC10988 | Wellcome Trust (Wellcome) | PubMed | PubMed | ||
| Wellcome Trust | United Kingdom | PubMed | PubMed | ||
| A109 | DH | National Institute for Health Research (NIHR) | PubMed | PubMed | ||
| C1298/A8362, A29911, FC10988 | Cancer Research UK (CRUK) | PubMed | PubMed |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Update of | 38106039 | Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinoma. | https://conductscience.org/library/papers/38106039 |
Source PubMed
References92
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28407145 | GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. | Nucleic Acids Res | 2017 | https://conductscience.org/library/papers/28407145 | PubMed |
| 2 | 28112740 | A somatic-mutational process recurrently duplicates germline susceptibility loci and tissue-specific super-enhancers in breast cancers. | Nat Genet | 2017 | https://conductscience.org/library/papers/28112740 | PubMed |
| 3 | 27135926 | Landscape of somatic mutations in 560 breast cancer whole-genome sequences. | Nature | 2016 | https://conductscience.org/library/papers/27135926 | PubMed |
| 4 | 26372948 | Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes. | Nat Biotechnol | 2015 | https://conductscience.org/library/papers/26372948 | PubMed |
| 5 | 29625055 | An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics. | Cell | 2018 | https://conductscience.org/library/papers/29625055 | PubMed |
| 6 | 26825632 | pVAC-Seq: A genome-guided in silico approach to identifying tumor neoantigens. | Genome Med | 2016 | https://conductscience.org/library/papers/26825632 | PubMed |
| 7 | 22581179 | Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs. | Bioinformatics | 2012 | https://conductscience.org/library/papers/22581179 | PubMed |
| 8 | 22608083 | The life history of 21 breast cancers. | Cell | 2012 | https://conductscience.org/library/papers/22608083 | PubMed |
| 9 | 31954095 | Candidate Cancer Driver Mutations in Distal Regulatory Elements and Long-Range Chromatin Interaction Networks. | Mol Cell | 2020 | https://conductscience.org/library/papers/31954095 | PubMed |
| 10 | 32024846 | Integrative pathway enrichment analysis of multivariate omics data. | Nat Commun | 2020 | https://conductscience.org/library/papers/32024846 | PubMed |
| 11 | 32873572 | Efficacy and Safety of Nivolumab Plus Ipilimumab versus Sunitinib in First-line Treatment of Patients with Advanced Sarcomatoid Renal Cell Carcinoma. | Clin Cancer Res | 2021 | https://conductscience.org/library/papers/32873572 | PubMed |
| 12 | 32025013 | The evolutionary history of 2,658 cancers. | Nature | 2020 | https://conductscience.org/library/papers/32025013 | PubMed |
| 13 | 22962449 | DELLY: structural variant discovery by integrated paired-end and split-read analysis. | Bioinformatics | 2012 | https://conductscience.org/library/papers/22962449 | PubMed |
| 14 | 28760909 | Circulating Tumor DNA Reveals Clinically Actionable Somatic Genome of Metastatic Bladder Cancer. | Clin Cancer Res | 2017 | https://conductscience.org/library/papers/28760909 | PubMed |
| 15 | 30371878 | COSMIC: the Catalogue Of Somatic Mutations In Cancer. | Nucleic Acids Res | 2019 | https://conductscience.org/library/papers/30371878 | PubMed |
| 16 | 32025012 | Patterns of somatic structural variation in human cancer genomes. | Nature | 2020 | https://conductscience.org/library/papers/32025012 | PubMed |
| 17 | 29301960 | Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma. | Science | 2018 | https://conductscience.org/library/papers/29301960 | PubMed |
| 18 | 34497419 | Using DNA sequencing data to quantify T cell fraction and therapy response. | Nature | 2021 | https://conductscience.org/library/papers/34497419 | PubMed |
| 19 | 28473526 | Modeling Renal Cell Carcinoma in Mice: Bap1 and Pbrm1 Inactivation Drive Tumor Grade. | Cancer Discov | 2017 | https://conductscience.org/library/papers/28473526 | PubMed |
| 20 | 21527027 | GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. | Genome Biol | 2011 | https://conductscience.org/library/papers/21527027 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42924582 | A false sense of hypoxia: Pro‑tumorigenic VHL‑HIF2α dysregulation in clear cell renal cell carcinoma (Review). | Mol Med Rep | 2026 | https://conductscience.org/library/papers/42924582 | PubMed |
| 42770303 | Molecular underpinnings of metastatic small renal masses. | JCI Insight | 2026 | https://conductscience.org/library/papers/42770303 | PubMed |
| 42465403 | A single chromosome 3p break initiates clear cell renal cell carcinoma evolution. | bioRxiv | 2026 | https://conductscience.org/library/papers/42465403 | PubMed |
| 41593170 | Nuclear receptor corepressor 1 is a potential diagnostic and prognostic biomarker in clear cell renal cell carcinoma. | Sci Rep | 2026 | https://conductscience.org/library/papers/41593170 | PubMed |
| 41563788 | Contrasting Features of Papillary and Chromophobe Renal Cell Carcinoma Revealed by Whole-Genome Sequencing. | Mol Cancer Res | 2026 | https://conductscience.org/library/papers/41563788 | PubMed |
| 41513925 | Distinct genomic, microenvironmental, and nephron signatures in VHL kidney cysts and tumors. | Sci Rep | 2026 | https://conductscience.org/library/papers/41513925 | PubMed |
| 41467947 | Integrating multi-omics data and machine learning to identify endocrine disrupting chemicals targeting key ccRCC-related genes. | Discov Oncol | 2025 | https://conductscience.org/library/papers/41467947 | PubMed |
| 41326661 | Deciphering genetic susceptibility to clear cell renal cell carcinoma. | Commun Biol | 2025 | https://conductscience.org/library/papers/41326661 | PubMed |
| 40978095 | Renal cell carcinoma with unusual morphological features: the clinical utility of next-generation sequencing in distinguishing renal cell tumors. | Am J Clin Exp Urol | 2025 | https://conductscience.org/library/papers/40978095 | PubMed |
| 40514379 | Clonal hematopoiesis in metastatic urothelial and renal cell carcinoma. | NPJ Precis Oncol | 2025 | https://conductscience.org/library/papers/40514379 | PubMed |
| 40489038 | Shared hub genes in membranous nephropathy and kidney renal clear cell carcinoma: investigating molecular overlap and tumor progression. | Discov Oncol | 2025 | https://conductscience.org/library/papers/40489038 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| VHL | 7428 | PubTator's text mining | https://conductscience.org/library/genes/7428 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39009593
GET https://conductscience.org/api/papers/v1/39009593/references?page=2